Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
Vise andre og tillknytning
2018 (engelsk)Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 178, nr 5, s. E332-E341Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus over the definition of the core domain of long-term control and how to measure it and (ii) to prioritize future areas of research for the measurement of the core domain of quality of life (QoL) in children. Moderated whole-group and small-group consensus discussions were informed by presentations of qualitative studies, systematic reviews and validation studies. Small-group allocations were performed a priori to ensure that each group included different stakeholders from a variety of geographical regions. Anonymous whole-group voting was carried out using handheld electronic voting pads according to pre-defined consensus rules. It was agreed by consensus that the long-term control domain should include signs, symptoms, quality of life and a patient global instrument. The group agreed that itch intensity should be measured when assessing long-term control of eczema in addition to the frequency of itch captured by the symptoms domain. There was no recommendation of an instrument for the core outcome domain of quality of life in children, but existing instruments were assessed for face validity and feasibility, and future work that will facilitate the recommendation of an instrument was agreed upon.

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2018. Vol. 178, nr 5, s. E332-E341
HSV kategori
Forskningsprogram
Folkhälsovetenskap
Identifikatorer
URN: urn:nbn:se:kau:diva-67487DOI: 10.1111/bjd.16543ISI: 000432553500006PubMedID: 29672835OAI: oai:DiVA.org:kau-67487DiVA, id: diva2:1214709
Tilgjengelig fra: 2018-06-07 Laget: 2018-06-07 Sist oppdatert: 2019-08-14bibliografisk kontrollert

Open Access i DiVA

fulltext(327 kB)15 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 327 kBChecksum SHA-512
94388aada427de0e9abe03f18b59432c3cf8963e302d07763228e169eb4f2efba09b2bb9184aa92541c68e393dbe6f65578ad428f4dd6a555390749ef748cd22
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

von Kobyletzki, Laura B.

Søk i DiVA

Av forfatter/redaktør
von Kobyletzki, Laura B.
Av organisasjonen
I samme tidsskrift
British Journal of Dermatology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 15 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 74 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf